Get Kybella Consent Form

KYBELLA® is the only FDA-approved injectable treatment that destroys fat cells in the treatment area under the chin to improve your profile.

KYBELLA® Post-Treatment Guidelines DO NOT participate in strenuous activities for 3 days following treatment. DO NOT scratch, pick or traumatize the area in any way. DO NOT massage or manipulate the injection site. a normal part of the process.

Generally, a good Kybella candidate is in relatively good health and concerned about excess fat in the submental region. However, good health and excess chin or neck fat alone are not enough to qualify.

Kybella is the first and only FDA-approved injectable drug that contours and improves the appearance of a double chin, jowls and other small pockets of fat. The medication causes the destruction of the fat cells.

It is specifically FDA-approved for the treatment of submental fat (fat beneath the chin). This means that numerous clinical studies have been performed and that Kybella has been proven safe for this purpose.

Kybella's most common side effects are pain, swelling, and bruising where it was injected. Other injection site reactions are also common. Rare but serious side effects are also possible. This includes more serious injection site reactions, difficulty swallowing, and nerve damage.

Development timeline for Kybella DateArticleApr 29, 2015Approval FDA Approves Kybella (deoxycholic acid) to Treat Submental Fullness, or 'Double Chin'Mar 9, 2015Kythera Biopharmaceuticals Announces FDA Advisory Committee Unanimously Recommends to Approve ATX-101 Mar 9, 2015

Background: Deoxycholic acid is an FDA-approved injectable for treatment of excess submental fat.